益佰制药预计2025年归母净利润为亏损2.85亿—3.42亿元

Core Viewpoint - Yibai Pharmaceutical is forecasting a significant net loss for 2025, with expected losses ranging from 285 million to 342 million yuan, indicating ongoing financial challenges for the company [1] Financial Performance - The company anticipates a 14% decline in revenue due to reduced sales of its main products [1] - Despite an expected 18% decrease in costs and expenses, the total costs will still exceed revenue, leading to the projected losses [1]